SEMCO TECHNOLOGIES SAS (ALSEM.PA) Fundamental Analysis & Valuation

EPA:ALSEM • FR0014010H01

Current stock price

45.55 EUR
-1.05 (-2.25%)
Last:

This ALSEM.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALSEM.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALSEM was profitable.
ALSEM.PA Yearly Net Income VS EBIT VS OCF VS FCFALSEM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 5M 10M

1.2 Ratios

  • ALSEM has a Return On Assets of 18.88%. This is amongst the best in the industry. ALSEM outperforms 83.10% of its industry peers.
  • Looking at the Return On Equity, with a value of 45.60%, ALSEM belongs to the top of the industry, outperforming 88.73% of the companies in the same industry.
  • ALSEM has a better Return On Invested Capital (39.86%) than 91.55% of its industry peers.
Industry RankSector Rank
ROA 18.88%
ROE 45.6%
ROIC 39.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSEM.PA Yearly ROA, ROE, ROICALSEM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 10 20 30 40 50

1.3 Margins

  • ALSEM's Profit Margin of 20.82% is fine compared to the rest of the industry. ALSEM outperforms 64.79% of its industry peers.
  • Looking at the Operating Margin, with a value of 29.31%, ALSEM is in the better half of the industry, outperforming 71.83% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 53.65%, ALSEM is in the better half of the industry, outperforming 69.01% of the companies in the same industry.
Industry RankSector Rank
OM 29.31%
PM (TTM) 20.82%
GM 53.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALSEM.PA Yearly Profit, Operating, Gross MarginsALSEM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALSEM.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALSEM is creating value.
  • The number of shares outstanding for ALSEM remains at a similar level compared to 1 year ago.
  • ALSEM has a worse debt/assets ratio than last year.
ALSEM.PA Yearly Shares OutstandingALSEM.PA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2M 4M 6M 8M 10M
ALSEM.PA Yearly Total Debt VS Total AssetsALSEM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 16.33 indicates that ALSEM is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 16.33, ALSEM is doing good in the industry, outperforming 78.87% of the companies in the same industry.
  • ALSEM has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • ALSEM has a Debt to Equity ratio (0.18) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 16.33
ROIC/WACC3.34
WACC11.93%
ALSEM.PA Yearly LT Debt VS Equity VS FCFALSEM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 1.75 indicates that ALSEM should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.75, ALSEM is doing worse than 84.51% of the companies in the same industry.
  • ALSEM has a Quick Ratio of 1.31. This is a normal value and indicates that ALSEM is financially healthy and should not expect problems in meeting its short term obligations.
  • ALSEM has a Quick ratio of 1.31. This is amonst the worse of the industry: ALSEM underperforms 81.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.31
ALSEM.PA Yearly Current Assets VS Current LiabilitesALSEM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALSEM.PA Growth Analysis

3.1 Past

  • ALSEM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.81%.
  • The Revenue has decreased by -5.36% in the past year.
EPS 1Y (TTM)-15.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, ALSEM will show a very strong growth in Earnings Per Share. The EPS will grow by 31.11% on average per year.
  • ALSEM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.80% yearly.
EPS Next Y42.42%
EPS Next 2Y36.55%
EPS Next 3Y35.37%
EPS Next 5Y31.11%
Revenue Next Year8.86%
Revenue Next 2Y15.94%
Revenue Next 3Y18.85%
Revenue Next 5Y19.8%

3.3 Evolution

ALSEM.PA Yearly Revenue VS EstimatesALSEM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 20M 40M 60M
ALSEM.PA Yearly EPS VS EstimatesALSEM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALSEM.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 70.08, the valuation of ALSEM can be described as expensive.
  • 70.42% of the companies in the same industry are cheaper than ALSEM, based on the Price/Earnings ratio.
  • ALSEM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.89.
  • A Price/Forward Earnings ratio of 37.64 indicates a quite expensive valuation of ALSEM.
  • Based on the Price/Forward Earnings ratio, ALSEM is valued a bit more expensive than 61.97% of the companies in the same industry.
  • ALSEM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 38.50.
Industry RankSector Rank
PE 70.08
Fwd PE 37.64
ALSEM.PA Price Earnings VS Forward Price EarningsALSEM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • ALSEM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALSEM is more expensive than 74.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 48.67
ALSEM.PA Per share dataALSEM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ALSEM's earnings are expected to grow with 35.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.65
PEG (5Y)N/A
EPS Next 2Y36.55%
EPS Next 3Y35.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALSEM.PA Dividend Analysis

5.1 Amount

  • ALSEM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALSEM.PA Fundamentals: All Metrics, Ratios and Statistics

SEMCO TECHNOLOGIES SAS

EPA:ALSEM (4/17/2026, 7:00:00 PM)

45.55

-1.05 (-2.25%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners13.68%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap467.80M
Revenue(TTM)32.00M
Net Income(TTM)6.66M
Analysts85
Price Target35.09 (-22.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)20.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE 70.08
Fwd PE 37.64
P/S 14.62
P/FCF N/A
P/OCF N/A
P/B 32.01
P/tB 33.09
EV/EBITDA 48.67
EPS(TTM)0.65
EY1.43%
EPS(NY)1.21
Fwd EY2.66%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.12
BVpS1.42
TBVpS1.38
PEG (NY)1.65
PEG (5Y)N/A
Graham Number4.56176 (-89.99%)
Profitability
Industry RankSector Rank
ROA 18.88%
ROE 45.6%
ROCE 53.43%
ROIC 39.86%
ROICexc 39.92%
ROICexgc 41.03%
OM 29.31%
PM (TTM) 20.82%
GM 53.65%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 0.28
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.31
Altman-Z 16.33
F-ScoreN/A
WACC11.93%
ROIC/WACC3.34
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y42.42%
EPS Next 2Y36.55%
EPS Next 3Y35.37%
EPS Next 5Y31.11%
Revenue 1Y (TTM)-5.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year8.86%
Revenue Next 2Y15.94%
Revenue Next 3Y18.85%
Revenue Next 5Y19.8%
EBIT growth 1Y-12.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.12%
EBIT Next 3Y35.59%
EBIT Next 5Y32.56%
FCF growth 1Y149.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.29%
OCF growth 3YN/A
OCF growth 5YN/A

SEMCO TECHNOLOGIES SAS / ALSEM.PA Fundamental Analysis FAQ

What is the fundamental rating for ALSEM stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALSEM.PA.


Can you provide the valuation status for SEMCO TECHNOLOGIES SAS?

ChartMill assigns a valuation rating of 1 / 10 to SEMCO TECHNOLOGIES SAS (ALSEM.PA). This can be considered as Overvalued.


Can you provide the profitability details for SEMCO TECHNOLOGIES SAS?

SEMCO TECHNOLOGIES SAS (ALSEM.PA) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for ALSEM stock?

The Price/Earnings (PE) ratio for SEMCO TECHNOLOGIES SAS (ALSEM.PA) is 70.08 and the Price/Book (PB) ratio is 32.01.


How financially healthy is SEMCO TECHNOLOGIES SAS?

The financial health rating of SEMCO TECHNOLOGIES SAS (ALSEM.PA) is 4 / 10.